文献速递神经肿瘤

利用单细胞测序对批量RNA测序数据中的肿瘤亚组进行分类和表征

Leveraging single-cell sequencing to classify and characterize tumor subgroups in bulk RNA-sequencing data.
PubMed 文献 · J Neurooncol · 2024-05-29

研究评估不同特征选择方案用于脑膜瘤分类,整合批量RNA测序(n=77)与单细胞数据(约1万个细胞)开发CLIPPR算法。仅用批量数据模型分类准确但约8%样本良恶性分子类别混淆,单细胞模型能分辨混淆亚组但整体准确率有限。CLIPPR整体准确率更优,在789例多机构批量脑膜瘤样本上验证并解决良恶性混淆,还用内部单细胞(约20万细胞)和TCGA胶质瘤批量数据(n=711)展示泛化性。

要点

  • CLIPPR整合单细胞模型、RNA推断的拷贝数变异信号与初始批量模型构建元模型。
  • 仅用批量转录组数据的方案约8%脑膜瘤样本良恶性分子类别混淆。
  • CLIPPR在789例多机构批量脑膜瘤样本上整体准确率更优并解决良恶性混淆。

核心结论

  • CLIPPR算法协同单细胞数据的分辨率与批量测序的深度,改进癌症亚组诊断并增进对其生物学理解。

研究设计与样本

  • 研究评估脑膜瘤分类中不同特征选择方案,整合批量(n=77样本)与单细胞(约1万个细胞)图谱的可解释特征,开发CLIPPR算法结合表现最佳的单细胞模型、RNA推断的拷贝数变异(CNV)信号与初始批量模型构建元模型。

主要发现

  • 仅依赖批量转录组数据的方案分类准确率良好,但在约8%脑膜瘤样本中出现良性与恶性分子类别混淆。
  • 基于脑膜瘤单细胞数据学习特征的模型能准确分辨批量转录组数据混淆的亚组,但整体准确率有限。
  • CLIPPR整体准确率更优,并在来自多机构的n=789批量脑膜瘤样本验证中解决良恶性混淆。
  • 利用内部单细胞(约20万细胞)与批量TCGA胶质瘤数据(n=711样本)展示算法的泛化性。

关键数值与推荐

  • 批量转录组数据方案在约8%脑膜瘤样本中混淆良性与恶性分子类别。
  • CLIPPR在n=789批量脑膜瘤样本上验证整体准确率更优并解决良恶性混淆。
  • 单细胞数据约1万个细胞用于训练,内部单细胞数据约20万细胞用于泛化性展示。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Accurate classification of cancer subgroups is essential for precision medicine, tailoring treatments to individual patients based on their cancer subtypes. In recent years, advances in high-throughput sequencing technologies have enabled the generation of large-scale transcriptomic data from cancer samples. These data have provided opportunities for developing computational methods that can improve cancer subtyping and enable better personalized treatment strategies. METHODS: Here in this study, we evaluated different feature selection schemes in the context of meningioma classification. To integrate interpretable features from the bulk (n = 77 samples) and single-cell profiling (∼ 10 K cells), we developed an algorithm named CLIPPR which combines the top-performing single-cell models, RNA-inferred copy number variation (CNV) signals, and the initial bulk model to create a meta-model. RESULTS: While the scheme relying solely on bulk transcriptomic data showed good classification accuracy, it exhibited confusion between malignant and benign molecular classes in approximately ∼ 8% of meningioma samples. In contrast, models trained on features learned from meningioma single-cell data accurately resolved the sub-groups confused by bulk-transcriptomic data but showed limited overall accuracy. CLIPPR showed superior overall accuracy and resolved benign-malignant confusion as validated on n = 789 bulk meningioma samples gathered from multiple institutions. Finally, we showed the generalizability of our algorithm using our in-house single-cell (∼ 200 K cells) and bulk TCGA glioma data (n = 711 samples). CONCLUSION: Overall, our algorithm CLIPPR synergizes the resolution of single-cell data with the depth of bulk sequencing and enables improved cancer sub-group diagnoses and insights into their biology.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Shetty A, Wang S, Khan AB, et al. Leveraging single-cell sequencing to classify and characterize tumor subgroups in bulk RNA-sequencing data. J Neurooncol. 2024. PMID: 38811523. doi:10.1007/s11060-024-04710-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。